Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (21)

Advertisement

Research Article Free access | 10.1172/JCI105726

The nature of human serum insulin-like activity (ILA): characterization of ILA in serum and serum fractions obtained by acid-ethanol extraction and adsorption chromatography

Philip L. Poffenbarger, John W. Ensinck, Dieter K. Hepp, and Robert H. Williams

Division of Endocrinology and Metabolism, Department of Medicine, University of Washington School of Medicine, Seattle, Washington

Find articles by Poffenbarger, P. in: JCI | PubMed | Google Scholar

Division of Endocrinology and Metabolism, Department of Medicine, University of Washington School of Medicine, Seattle, Washington

Find articles by Ensinck, J. in: JCI | PubMed | Google Scholar

Division of Endocrinology and Metabolism, Department of Medicine, University of Washington School of Medicine, Seattle, Washington

Find articles by Hepp, D. in: JCI | PubMed | Google Scholar

Division of Endocrinology and Metabolism, Department of Medicine, University of Washington School of Medicine, Seattle, Washington

Find articles by Williams, R. in: JCI | PubMed | Google Scholar

Published February 1, 1968 - More info

Published in Volume 47, Issue 2 on February 1, 1968
J Clin Invest. 1968;47(2):301–320. https://doi.org/10.1172/JCI105726.
© 1968 The American Society for Clinical Investigation
Published February 1, 1968 - Version history
View PDF
Abstract

Studies were undertaken in an attempt to clarify the apparent heterogeneous nature of human serum insulin-like activity. Methods of preparative zone electrophoresis on Pevikon, acid-ethanol extraction of trichloroacetic acid serum protein precipitates, adsorption chromatography on DEAE-cellulose and Dowex 50, gel filtration chromatography, and insulin antiserum immunoreactivity were used. The results establish the presence of a substance in serum with in vitro biological properties similar to insuln but with different physicochemical properties. The major portion of serum ILA measured by bioassay techniques can be attributed to the effects of this substance. Whereas the in vitro biological effects of this substance on muscle and adipose cells were similar to those of crystalline insulin, the substance is distinguished from insulin by: (1) the failure of insulin antiserum to inhibit its in vitro biological effect; (2) a slower electrophoretic mobility (in the gamma-beta globulin zone); and (3) a larger molecular weight, between 40,000 and 50,000 in these studies. It is similar to insulin since both are soluble in acid-ethanol. The results further indicate that previously described insulin-like activity in gamma-beta globulin preparations, the major portion of total serum insulin activity described in acid-ethanol extracts of serum, “bound” insulin, “atypical” insulin, and antibody nonsuppressible insulin-like activity bioassayed in diluted serum are all one and the same substance.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 301
page 301
icon of scanned page 302
page 302
icon of scanned page 303
page 303
icon of scanned page 304
page 304
icon of scanned page 305
page 305
icon of scanned page 306
page 306
icon of scanned page 307
page 307
icon of scanned page 308
page 308
icon of scanned page 309
page 309
icon of scanned page 310
page 310
icon of scanned page 311
page 311
icon of scanned page 312
page 312
icon of scanned page 313
page 313
icon of scanned page 314
page 314
icon of scanned page 315
page 315
icon of scanned page 316
page 316
icon of scanned page 317
page 317
icon of scanned page 318
page 318
icon of scanned page 319
page 319
icon of scanned page 320
page 320
Version history
  • Version 1 (February 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (21)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts